Image Source: Unsplash
 

The munKNEE "Rags-to-Riches" Portfolio consists of 16 cannabis, psychedelic, and plant-based food stocks with market capitalizations between $400M and $3.0B - an average of $968M. The munKNEE "Multi-bagger" Portfolio, in comparison, consists of the next largest 9 stocks in the same four indexes which have market capitalizations between $75M and $399M with an average of $122M.

Below is an update on how the various categories in the Portfolio, and their constituents, performed in March and have performed YTD.

1. American Cannabis MSO constituents:
   • Columbia Care )CCHWF): DOWN 14.8%; DOWN 30.7% YTD;
   • Cresco (CRLBF): DOWN 10.4% in March; DOWN 11.4% YTD;
   • Curaleaf (CURLF): DOWN 21.9% in March; DOWN 27.9% YTD;
   • Green Thumb (GTBIF): DOWN 7.2% in March; DOWN 8.7% YTD;
   • TerrAscend (TRSSF): DOWN 3.2% in March; UP 38.2% YTD;
   • Trulieve (TCNNF): DOWN 13.1% in March; DOWN 26.1% YTD; and
   • Verano (VRNOF): DOWN 1.7% in March; DOWN 5.2% YTD.
     • In total: DOWN 15.7% in March; DOWN 20.1% YTD and
     • an average 12-month price target of representing a 203% increase from the March 31st price
   • For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) was DOWN 131% in March; DOWN 18.6% YTD.
2. Canadian Cannabis LP constituents:
   • Canopy Growth (CGC):DOWN 24.2% in March; DOWN 22.9% YTD;;
   • Cronos (CRON): DOWN 1.5% in March; DOWN 23.0% YTD; and
   • Tilray (TLRY): DOWN 10.6% in March; DOWN 5.2% YTD.
     • In total: DOWN 12.5% in March; DOWN 16.6% YTD and
     • an average year-end price target of representing a 57% increase from the March 31st price
   • For comparison purposes, the Global X Cannabis ETF (POTX) was DOWN 15.0% in March; DOWN 18.3% YTD.
3. Psychedelic Drug Stock constituents:
   • Atai (ATAI): UP 7.7% in March; DOWN 29.8% YTD;
   • Compass Pathways (CMPS): UP 7.4%% in March; UP 27.1% YTD;
   • GH Research (GHRS): DOWN 16.6% in March; DOWN 16.2% YTD and
   • Incannex (IXHL): UP 14.5%; DOWN 22.1% YTD.
     • In total: DOWN 0.7% in March; DOWN 3.6% YTD and
     • an average year-end price target of representing a 363% increase from the March 31st price
   • For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) was DOWN 11.3% in March; UP 1.1% YTD.
4. Plant-Based Food Stock constituents:
   • Beyond Meat (BYND): DOWN 9.0% in March; UP 33.0% YTD; and
   • Oatly Group (OTLY): UP 10.0% in March; UP 39.1% YTD.
     • In total: DOWN 6.9% in March; UP 32.9% YTD and
     • an average year-end price target of representing a 4.4% DECREASE from the March 31st price
   • No comparable plant-based food stock ETFs
      

In Conclusion

• The "Rags-to-Riches" Portfolio was DOWN 8.6% in March and DOWN 3.9% YTD;
• our "Multi-bagger" Portfolio was UP 5.7% in March and DOWN 12.7% YTD while
• the S&P 500 was UP 5.2% in March and UP 7.0% YTD.

More By This Author:

Revamped American Cannabis MSO Index Declined 15% In March
"Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD
Our Aggressive ETF Portfolio Is Outperforming The S&P 500 By A 2-To-1 Margin